Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 2 1Phase 1 1

Status

Unknown 1Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 16Breast 10Thoracic 7Genitourinary 7Plasma cell 6Lymphoid 4CNS 3Other solid neoplasm 2Other hematologic neoplasm 2Classical hematology 2Tumor-Agnostic 1Sarcoma 1Gynecologic 1

Conditions

Waldenstrom Macroglobulinemia 1Sprains and Strains 1Sepsis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Febrile Neutropenia 1

Interventions

Rituximab 1401Cyclophosphamide 1305Vincristine 668Doxorubicin 587Etoposide 527Prednisone 510Cytarabine 486fludarabine 469Methotrexate 445Dexamethasone 413fludarabine phosphate 400Lenalidomide 356Filgrastim 343Bendamustine Hydrochloride 282Radiotherapy 267venetoclax 260ibrutinib 258obinutuzumab 235Peripheral Blood Stem Cell Transplantation 234Melphalan 230Granulocyte Colony-Stimulating Factor 215Bortezomib 204Gemcitabine 202Busulfan 188Whole-Body Irradiation 187Mycophenolic Acid 175Tacrolimus 165Specimen Handling 162Magnetic Resonance Spectroscopy 155Calcium Dobesilate 150

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Simvastatin × Lymphoid × Clear all
NCT04514029 2026-01-08

Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel

Masonic Cancer Center, University of Minnesota

Phase EARLY_PHASE1 Active not recruiting
37 enrolled
Lymphoid

Lymphoma, Neurotoxicity Syndromes

NCT05133310 2022-01-04

Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia

Hospital General de Mexico

Phase 4 Unknown
108 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Sprains and Strains, Sepsis, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT00575965 2015-12-16

Simvastatin in Waldenstrom's Macroglobulinemia

Dana-Farber Cancer Institute

Phase 2 Terminated
18 enrolled 5 charts
Lymphoid

Waldenstrom Macroglobulinemia

NCT00828282 2014-05-26

High-dose HMG-CoA Inhibitor Simvastatin Relapsed CLL

University of Kentucky

Phase 1 Completed
3 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡